Combined Thalidomide and Temozolomide Treatment in Patients with Glioblastoma Multiforme

By Baumann Fabian   Bjeljac Miroslava   Kollias Spyros   Baumert Brigitta   Brandner Sebastian   Rousson Valentin   Yonekawa Yasuhiro   Bernays René  

Journal of Neuro-Oncology, Vol. 67, Iss. 1-2, 2004-03 ,pp. : 191-200

Springer Publishing Company

Access to resources Recommend Favorite

Necrosis is not induced by gadolinium neutron capture in glioblastoma multiforme cells

By Yasui Linda   Owens Kathryn  

International Journal of Radiation Biology, Vol. 88, Iss. 12, 2012-12 ,pp. : 980-990

Informa Healthcare

Access to resources Recommend Favorite

Neoadjuvant targeting of glioblastoma multiforme with radiolabeled DOTAGA–substance P—results from a phase I study

By Cordier Dominik   Forrer Flavio   Kneifel Stefan   Sailer Martin   Mariani Luigi   Mäcke Helmut   Müller-Brand Jan   Merlo Adrian  

Journal of Neuro-Oncology, Vol. 100, Iss. 1, 2010-10 ,pp. : 129-136

Springer Publishing Company

Access to resources Recommend Favorite

Combination Treatment for Glioblastoma Cells with Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand and Oncolytic Adenovirus Delta-24

By Tsamis Konstantinos I.   Alexiou George A.   Vartholomatos Evrysthenis   Kyritsis Athanasios P.  

Cancer Investigation, Vol. 31, Iss. 9, 2013-11 ,pp. : 630-638

Informa Healthcare

Access to resources Recommend Favorite

Targeted Toxins for Glioblastoma Multiforme: Pre-Clinical Studies and Clinical Implementation

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 11, Iss. 8, 2011-10 ,pp. : 729-738

Bentham Science Publishers

Access to resources Recommend Favorite